Adolfo García-Sastre
#67,812
Most Influential Person Now
American microbiologist
Adolfo García-Sastre's AcademicInfluence.com Rankings
Adolfo García-Sastrebiology Degrees
Biology
#2512
World Rank
#3975
Historical Rank
#1117
USA Rank
Virology
#40
World Rank
#42
Historical Rank
#17
USA Rank
Microbiology
#77
World Rank
#97
Historical Rank
#34
USA Rank
Download Badge
Biology
Adolfo García-Sastre's Degrees
- PhD Microbiology University of Salamanca
Why Is Adolfo García-Sastre Influential?
(Suggest an Edit or Addition)According to Wikipedia, Adolfo García-Sastre, is a Spanish professor of Medicine and Microbiology and co-director of the Global Health & Emerging Pathogens Institute at the Icahn School of Medicine at Mount Sinai in New York City. His research into the biology of influenza viruses has been at the forefront of medical advances in epidemiology.
Adolfo García-Sastre's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing (2020) (3012)
- Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. (2013) (1741)
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 (2020) (1524)
- Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus (2005) (1203)
- A serological assay to detect SARS-CoV-2 seroconversion in humans (2020) (1067)
- Distinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity (2007) (1047)
- Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. (1998) (1031)
- Type 1 Interferons and the Virus-Host Relationship: A Lesson in Détente (2006) (888)
- Programming the magnitude and persistence of antibody responses with innate immunity (2010) (886)
- A serological assay to detect SARS-CoV-2 seroconversion in humans (2020) (879)
- Human Host Factors Required for Influenza Virus Replication (2010) (825)
- Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. (2009) (774)
- Meta- and Orthogonal Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding. (2015) (773)
- Rescue of influenza A virus from recombinant DNA. (2007) (762)
- Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity (2013) (758)
- The Global Phosphorylation Landscape of SARS-CoV-2 Infection (2020) (651)
- Inhibition of interferon signaling by dengue virus (2003) (649)
- Activation of Interferon Regulatory Factor 3 Is Inhibited by the Influenza A Virus NS1 Protein (2000) (639)
- H5N1 and 1918 Pandemic Influenza Virus Infection Results in Early and Excessive Infiltration of Macrophages and Neutrophils in the Lungs of Mice (2008) (637)
- Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling. (2016) (624)
- Inhibition of Retinoic Acid-Inducible Gene I-Mediated Induction of Beta Interferon by the NS1 Protein of Influenza A Virus (2006) (608)
- Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon (2000) (592)
- Animal models for COVID-19 (2020) (582)
- Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus (2006) (577)
- Influenza A viruses: new research developments (2011) (566)
- A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission (2007) (552)
- Induction of ICOS+CXCR3+CXCR5+ TH Cells Correlates with Antibody Responses to Influenza Vaccination (2013) (549)
- Pathogenicity of Influenza Viruses with Genes from the 1918 Pandemic Virus: Functional Roles of Alveolar Macrophages and Neutrophils in Limiting Virus Replication and Mortality in Mice (2005) (532)
- Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses (2005) (530)
- IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses (2007) (518)
- Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain (2010) (514)
- Influenza (2018) (502)
- The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3 (2003) (478)
- Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. (2009) (474)
- The Ebola virus VP35 protein functions as a type I IFN antagonist. (2000) (466)
- Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein (2007) (463)
- A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing (2020) (456)
- Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms (2020) (444)
- Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. (2004) (441)
- Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity (2017) (439)
- The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. (2001) (433)
- Discovery of SARS-CoV-2 Antivirals through Large-scale Drug Repositioning (2020) (422)
- Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: The role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza (2002) (399)
- Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus (2010) (389)
- Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing (2010) (386)
- A Single Amino Acid Substitution in 1918 Influenza Virus Hemagglutinin Changes Receptor Binding Specificity (2005) (384)
- NS5 of Dengue Virus Mediates STAT2 Binding and Degradation (2009) (381)
- Influenza Virus NS1 Protein Counteracts PKR-Mediated Inhibition of Replication (2000) (378)
- Newcastle Disease Virus (NDV)-Based Assay Demonstrates Interferon-Antagonist Activity for the NDV V Protein and the Nipah Virus V, W, and C Proteins (2003) (374)
- Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus (2009) (374)
- Influenza Virus PB1-F2 Protein Induces Cell Death through Mitochondrial ANT3 and VDAC1 (2005) (369)
- Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation (2014) (364)
- Ovarian Tumor Domain-Containing Viral Proteases Evade Ubiquitin- and ISG15-Dependent Innate Immune Responses (2007) (352)
- Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency (2015) (347)
- The intracellular sites of early replication and budding of SARS-coronavirus (2007) (345)
- Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. (2001) (334)
- The guinea pig as a transmission model for human influenza viruses. (2006) (332)
- Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. (2000) (332)
- SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling (2020) (328)
- The Role of Interferon in Influenza Virus Tissue Tropism (1998) (314)
- Influenza Virus Evades Innate and Adaptive Immunity via the NS1 Protein (2006) (312)
- Multiple Functions of the IKK-Related Kinase IKKε in Interferon-Mediated Antiviral Immunity (2007) (304)
- Inhibition of Beta Interferon Induction by Severe Acute Respiratory Syndrome Coronavirus Suggests a Two-Step Model for Activation of Interferon Regulatory Factor 3 (2005) (302)
- Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes (2010) (301)
- Influenza Research Database: an integrated bioinformatics resource for influenza research and surveillance (2012) (298)
- Type I IFN Modulates Innate and Specific Antiviral Immunity1 (2000) (297)
- A Recombinant Influenza A Virus Expressing anRNA-Binding-Defective NS1 Protein Induces High Levels of BetaInterferon and Is Attenuated inMice (2003) (296)
- Ten Strategies of Interferon Evasion by Viruses (2017) (295)
- Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer (2020) (291)
- The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. (2013) (282)
- Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes (2001) (282)
- Dissection of the Influenza A Virus Endocytic Routes Reveals Macropinocytosis as an Alternative Entry Pathway (2011) (280)
- Species-Specific Inhibition of RIG-I Ubiquitination and IFN Induction by the Influenza A Virus NS1 Protein (2012) (278)
- TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. (2014) (271)
- SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters (2022) (267)
- Suppression of the antiviral response by an influenza histone mimic (2012) (266)
- Mutations in the NS1 Protein of Swine Influenza Virus Impair Anti-Interferon Activity and Confer Attenuation in Pigs (2005) (257)
- SARS-CoV-2 spike E484K mutation reduces antibody neutralisation (2021) (253)
- Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses (2012) (252)
- Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection (2017) (252)
- Transcription Elongation Can Affect Genome 3D Structure (2018) (251)
- A plasmid-based reverse genetics system for influenza A virus (1996) (250)
- An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike (2020) (249)
- Attenuation of Equine Influenza Viruses through Truncations of the NS1 Protein (2005) (241)
- Live Attenuated Influenza Viruses Containing NS1 Truncations as Vaccine Candidates against H5N1 Highly Pathogenic Avian Influenza (2008) (240)
- Viral tricks to grid-lock the type I interferon system (2010) (239)
- Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. (2007) (236)
- Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. (2006) (232)
- IRF3 and IRF7 Phosphorylation in Virus-infected Cells Does Not Require Double-stranded RNA-dependent Protein Kinase R or IκB Kinase but Is Blocked by Vaccinia Virus E3L Protein* (2001) (228)
- Newcastle Disease Virus V Protein Is a Determinant of Host Range Restriction (2003) (226)
- Inhibition of the Type I Interferon Response by the Nucleoprotein of the Prototypic Arenavirus Lymphocytic Choriomeningitis Virus (2006) (224)
- The Influenza Virus Protein PB1-F2 Inhibits the Induction of Type I Interferon at the Level of the MAVS Adaptor Protein (2011) (223)
- Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. (2007) (222)
- Virulence-Associated Substitution D222G in the Hemagglutinin of 2009 Pandemic Influenza A(H1N1) Virus Affects Receptor Binding (2010) (216)
- Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. (2014) (214)
- MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells (2020) (213)
- Cross-presenting CD103+ dendritic cells are protected from influenza virus infection. (2012) (213)
- Induction and evasion of type I interferon responses by influenza viruses. (2011) (212)
- Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs (2014) (212)
- Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air (2009) (211)
- Influenza A virus-generated small RNAs regulate the switch from transcription to replication (2010) (209)
- Transmission of Influenza Virus via Aerosols and Fomites in the Guinea Pig Model (2009) (207)
- Nipah Virus V and W Proteins Have a Common STAT1-Binding Domain yet Inhibit STAT1 Activation from the Cytoplasmic and Nuclear Compartments, Respectively (2004) (206)
- Comparative Flavivirus-Host Protein Interaction Mapping Reveals Mechanisms of Dengue and Zika Virus Pathogenesis (2018) (205)
- The NS5 Protein of the Virulent West Nile Virus NY99 Strain Is a Potent Antagonist of Type I Interferon-Mediated JAK-STAT Signaling (2010) (204)
- Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans (2014) (203)
- The Influenza A Virus NS1 Protein Inhibits Activation of Jun N-Terminal Kinase and AP-1 Transcription Factors (2002) (199)
- Origins of the 2009 H1N1 influenza pandemic in swine in Mexico (2016) (199)
- Transcriptional role of p53 in interferon-mediated antiviral immunity (2008) (197)
- After the pandemic: perspectives on the future trajectory of COVID-19 (2021) (197)
- Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A (2021) (197)
- A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses (2017) (190)
- Virulence determinants of pandemic influenza viruses. (2011) (190)
- Protection of Mice against Lethal Challenge with 2009 H1N1 Influenza A Virus by 1918-Like and Classical Swine H1N1 Based Vaccines (2010) (189)
- Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. (2004) (189)
- Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene (2007) (189)
- Vaccination of Pigs against Swine Influenza Viruses by Using an NS1-Truncated Modified Live-Virus Vaccine (2006) (188)
- Influenza A virus transmission bottlenecks are defined by infection route and recipient host. (2014) (186)
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing (2020) (184)
- Dengue Virus Co-opts UBR4 to Degrade STAT2 and Antagonize Type I Interferon Signaling (2013) (184)
- The Mx1 Gene Protects Mice against the Pandemic 1918 and Highly Lethal Human H5N1 Influenza Viruses (2007) (182)
- Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses (2013) (181)
- Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling. (2013) (177)
- Differential Inhibition of Type I Interferon Induction by Arenavirus Nucleoproteins (2007) (177)
- An Immunocompetent Mouse Model of Zika Virus Infection. (2018) (175)
- SARS-CoV-2 infection, disease and transmission in domestic cats (2020) (174)
- Mouse STAT2 restricts early dengue virus replication. (2010) (172)
- Global Host Immune Response: Pathogenesis and Transcriptional Profiling of Type A Influenza Viruses Expressing the Hemagglutinin and Neuraminidase Genes from the 1918 Pandemic Virus (2004) (171)
- Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus (2008) (166)
- Inefficient Control of Host Gene Expression by the 2009 Pandemic H1N1 Influenza A Virus NS1 Protein (2010) (165)
- An Unconventional NLS is Critical for the Nuclear Import of the Influenza A Virus Nucleoprotein and Ribonucleoprotein (2005) (165)
- Host- and Strain-Specific Regulation of Influenza Virus Polymerase Activity by Interacting Cellular Proteins (2011) (162)
- Innate immune evasion strategies of influenza viruses. (2010) (156)
- Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility (2013) (155)
- Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. (2007) (155)
- Influenza A Virus Strains Differ in Sensitivity to the Antiviral Action of Mx-GTPase (2008) (152)
- PB1-F2 Expression by the 2009 Pandemic H1N1 Influenza Virus Has Minimal Impact on Virulence in Animal Models (2010) (147)
- H3N2 Influenza Virus Infection Induces Broadly Reactive Hemagglutinin Stalk Antibodies in Humans and Mice (2013) (145)
- VIRUSES AND THE TYPE I INTERFERON ANTIVIRAL SYSTEM: INDUCTION AND EVASION (2002) (144)
- Evolution of enhanced innate immune evasion by SARS-CoV-2 (2021) (144)
- PQBP1 Is a Proximal Sensor of the cGAS-Dependent Innate Response to HIV-1 (2015) (143)
- An In Vitro Microneutralization Assay for SARS‐CoV‐2 Serology and Drug Screening (2020) (141)
- alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s). (2007) (141)
- Recombinant Newcastle Disease Virus as a Vaccine Vector (2001) (140)
- Induction of type I interferon by RNA viruses: cellular receptors and their substrates (2009) (138)
- Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. (2007) (138)
- A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial (2020) (138)
- Negative-strand RNA viruses: genetic engineering and applications. (1996) (138)
- Reverse genetics studies on the filamentous morphology of influenza A virus. (2003) (137)
- Effects of Influenza A Virus NS1 Protein on Protein Expression: the NS1 Protein Enhances Translation and Is Not Required for Shutoff of Host Protein Synthesis (2002) (137)
- Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience (2021) (136)
- Transmission of Pandemic H1N1 Influenza Virus and Impact of Prior Exposure to Seasonal Strains or Interferon Treatment (2009) (135)
- ISG15 deficiency and increased viral resistance in humans but not mice (2016) (135)
- A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface (2019) (135)
- Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (2016) (132)
- Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus (2002) (132)
- NF-κB RelA Subunit Is Crucial for Early IFN-β Expression and Resistance to RNA Virus Replication (2010) (132)
- Peptide-Mediated Interference with Influenza A Virus Polymerase (2007) (131)
- Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses. (2003) (129)
- Oncolytic vesicular stomatitis virus for treatment of orthotopic hepatocellular carcinoma in immune-competent rats. (2003) (128)
- Protection against Respiratory Syncytial Virus by a Recombinant Newcastle Disease Virus Vector (2006) (128)
- The Early Interferon Response to Rotavirus Is Regulated by PKR and Depends on MAVS/IPS-1, RIG-I, MDA-5, and IRF3 (2011) (127)
- Differential Contribution of PB1-F2 to the Virulence of Highly Pathogenic H5N1 Influenza A Virus in Mammalian and Avian Species (2011) (127)
- Mice Lacking the ISG15 E1 Enzyme UbE1L Demonstrate Increased Susceptibility to both Mouse-Adapted and Non-Mouse-Adapted Influenza B Virus Infection (2008) (127)
- Assessment of Influenza Virus Hemagglutinin Stalk-Based Immunity in Ferrets (2014) (126)
- The M Segment of the 2009 New Pandemic H1N1 Influenza Virus Is Critical for Its High Transmission Efficiency in the Guinea Pig Model (2011) (125)
- ICOS+PD-1+CXCR3+ T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination (2016) (125)
- Phosphorylation-Mediated Negative Regulation of RIG-I Antiviral Activity (2010) (124)
- Cellular Localization and Antigenic Characterization of Crimean-Congo Hemorrhagic Fever Virus Glycoproteins (2005) (124)
- The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon. (2014) (123)
- Integrated Molecular Signature of Disease: Analysis of Influenza Virus-Infected Macaques through Functional Genomics and Proteomics (2006) (123)
- 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales (2020) (122)
- Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus (1995) (122)
- The NS1 protein: a multitasking virulence factor. (2015) (122)
- Functional Replacement of the Carboxy-Terminal Two-Thirds of the Influenza A Virus NS1 Protein with Short Heterologous Dimerization Domains (2002) (121)
- Arterivirus and Nairovirus Ovarian Tumor Domain-Containing Deubiquitinases Target Activated RIG-I To Control Innate Immune Signaling (2011) (121)
- Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 (2021) (120)
- Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. (1994) (120)
- Virus-induced senescence is a driver and therapeutic target in COVID-19 (2021) (120)
- In Vivo Ligands of MDA5 and RIG-I in Measles Virus-Infected Cells (2014) (117)
- The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera. (2021) (116)
- Spatial-Temporal Lineage Restrictions of Embryonic p63+ Progenitors Establish Distinct Stem Cell Pools in Adult Airways. (2018) (116)
- Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression (2021) (116)
- Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I. (2015) (115)
- Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry (2018) (114)
- Mechanisms of inhibition of the host interferon α/β-mediated antiviral responses by viruses (2002) (114)
- Preexisting human antibodies neutralize recently emerged H7N9 influenza strains. (2015) (113)
- Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKε kinase-mediated antiviral response. (2014) (112)
- Transcription Factor Redundancy Ensures Induction of the Antiviral State* (2010) (112)
- Macroautophagy Proteins Control MHC Class I Levels on Dendritic Cells and Shape Anti-viral CD8(+) T Cell Responses. (2016) (111)
- Live Attenuated Influenza Vaccine Provides Superior Protection from Heterologous Infection in Pigs with Maternal Antibodies without Inducing Vaccine-Associated Enhanced Respiratory Disease (2012) (109)
- Influenza-Infected Neutrophils within the Infected Lungs Act as Antigen Presenting Cells for Anti-Viral CD8+ T Cells (2012) (109)
- Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2 (2021) (109)
- Variations in the Hemagglutinin of the 2009 H1N1 Pandemic Virus: Potential for Strains with Altered Virulence Phenotype? (2010) (108)
- Identification of Amino Acid Residues Critical for the Anti-Interferon Activity of the Nucleoprotein of the Prototypic Arenavirus Lymphocytic Choriomeningitis Virus (2009) (108)
- Detection of Respiratory Viruses and Subtype Identification of Influenza A Viruses by GreeneChipResp Oligonucleotide Microarray (2007) (108)
- Maternal Influenza Viral Infection Causes Schizophrenia-Like Alterations of 5-HT2A and mGlu2 Receptors in the Adult Offspring (2011) (108)
- Oseltamivir-Resistant Variants of the 2009 Pandemic H1N1 Influenza A Virus Are Not Attenuated in the Guinea Pig and Ferret Transmission Models (2010) (108)
- The NS1 Protein of a Human Influenza Virus Inhibits Type I Interferon Production and the Induction of Antiviral Responses in Primary Human Dendritic and Respiratory Epithelial Cells (2009) (108)
- A genetically engineered influenza A virus with ras-dependent oncolytic properties. (2001) (107)
- Glycosylations in the Globular Head of the Hemagglutinin Protein Modulate the Virulence and Antigenic Properties of the H1N1 Influenza Viruses (2013) (107)
- Generation of recombinant influenza virus from plasmid DNA. (2010) (107)
- Negative Role of RIG-I Serine 8 Phosphorylation in the Regulation of Interferon-β Production* (2010) (107)
- Hantaan Virus Nucleocapsid Protein Binds to Importin α Proteins and Inhibits Tumor Necrosis Factor Alpha-Induced Activation of Nuclear Factor Kappa B (2008) (106)
- Influenza B Virus NS1-Truncated Mutants: Live-Attenuated Vaccine Approach (2008) (106)
- InTRIMsic immunity: Positive and negative regulation of immune signaling by tripartite motif proteins (2014) (105)
- Immunological imprinting of the antibody response in COVID-19 patients (2021) (105)
- ATPase‐driven oligomerization of RIG‐I on RNA allows optimal activation of type‐I interferon (2013) (105)
- A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies (2017) (105)
- Nonconserved nucleotides at the 3' and 5' ends of an influenza A virus RNA play an important role in viral RNA replication. (1996) (104)
- Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection. (2016) (103)
- Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. (1996) (103)
- MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection (2018) (103)
- Hijacking of RIG-I Signaling Proteins into Virus-Induced Cytoplasmic Structures Correlates with the Inhibition of Type I Interferon Responses (2014) (102)
- Hemagglutinin-Pseudotyped Green Fluorescent Protein-Expressing Influenza Viruses for the Detection of Influenza Virus Neutralizing Antibodies (2009) (102)
- The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera (2021) (102)
- Defining the antibody cross-reactome against the influenza virus surface glycoproteins (2017) (101)
- A Sendai Virus-Derived RNA Agonist of RIG-I as a Virus Vaccine Adjuvant (2012) (101)
- Plasmid-only rescue of influenza A virus vaccine candidates. (2001) (101)
- Severe influenza pneumonitis in children with inherited TLR3 deficiency (2019) (101)
- Inhibition of the Alpha/Beta Interferon Response by Mouse Hepatitis Virus at Multiple Levels (2007) (100)
- Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses. (2009) (100)
- Engineered RNA viral synthesis of microRNAs (2010) (99)
- Integration of Clinical Data, Pathology, and cDNA Microarrays in Influenza Virus-Infected Pigtailed Macaques (Macaca nemestrina) (2004) (97)
- An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus (2014) (96)
- Attenuated influenza virus vaccines with modified NS1 proteins. (2009) (96)
- Influenza virus exploits tunneling nanotubes for cell-to-cell spread (2017) (95)
- Expression of a foreign protein by influenza A virus (1994) (95)
- Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease (2011) (94)
- Hemagglutinin (HA) Proteins from H1 and H3 Serotypes of Influenza A Viruses Require Different Antigen Designs for the Induction of Optimal Protective Antibody Responses as Studied by Codon-Optimized HA DNA Vaccines (2006) (94)
- Recombinant Paramyxovirus Type 1-Avian Influenza-H7 Virus as a Vaccine for Protection of Chickens Against Influenza and Newcastle Disease (2003) (93)
- Evasion of innate and adaptive immune responses by influenza A virus (2010) (92)
- Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice. (1998) (92)
- Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms (2021) (92)
- Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant (2021) (91)
- A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals (2020) (91)
- Blocking Interhost Transmission of Influenza Virus by Vaccination in the Guinea Pig Model (2009) (89)
- Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene. (1997) (87)
- Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses. (2008) (87)
- Structure of NS3 helicase from Zika virus (2016) (87)
- Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection (2020) (86)
- Recombinant Newcastle Disease Virus as a Vaccine Vector for Cancer Therapy (2008) (86)
- Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-beta enhancer. (2007) (85)
- ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA (2015) (84)
- Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination (2006) (84)
- The N- and C-Terminal Domains of the NS1 Protein of Influenza B Virus Can Independently Inhibit IRF-3 and Beta Interferon Promoter Activation (2004) (84)
- BioHealthBase: informatics support in the elucidation of influenza virus host–pathogen interactions and virulence (2007) (84)
- Complete-Proteome Mapping of Human Influenza A Adaptive Mutations: Implications for Human Transmissibility of Zoonotic Strains (2010) (83)
- Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial (2019) (83)
- The DBA.2 Mouse Is Susceptible to Disease following Infection with a Broad, but Limited, Range of Influenza A and B Viruses (2011) (82)
- SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids (2021) (82)
- Constitutive resistance to viral infection in human CD141+ dendritic cells (2017) (82)
- Genetically engineered Newcastle disease virus for malignant melanoma therapy (2009) (81)
- Genetic manipulation of negative-strand RNA virus genomes. (1993) (81)
- Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses. (2002) (81)
- Cellular RNA Binding Proteins NS1-BP and hnRNP K Regulate Influenza A Virus RNA Splicing (2013) (81)
- TRIM25 in the Regulation of the Antiviral Innate Immunity (2017) (81)
- Prime-Boost Immunization Schedules Based on Influenza Virus and Vaccinia Virus Vectors Potentiate Cellular Immune Responses against Human Immunodeficiency Virus Env Protein Systemically and in the Genitorectal Draining Lymph Nodes (2003) (80)
- p53 Serves as a Host Antiviral Factor That Enhances Innate and Adaptive Immune Responses to Influenza A Virus (2011) (80)
- Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry. (2008) (78)
- Dengue Virus Immunity Increases Zika Virus‐Induced Damage during Pregnancy (2019) (78)
- MHC class II proteins mediate cross-species entry of bat influenza viruses (2019) (77)
- MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies (2013) (77)
- Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection (2020) (77)
- Influenza virus mRNA trafficking through host nuclear speckles (2016) (76)
- Species-Specific Antagonism of Host ISGylation by the Influenza B Virus NS1 Protein (2010) (76)
- rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy. (2008) (75)
- HERC6 Is the Main E3 Ligase for Global ISG15 Conjugation in Mouse Cells (2012) (75)
- Inhibition of the Ubiquitin-Proteasome System Affects Influenza A Virus Infection at a Postfusion Step (2010) (75)
- Optimization of Human Immunodeficiency Virus Gag Expression by Newcastle Disease Virus Vectors for the Induction of Potent Immune Responses (2008) (75)
- Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus (2010) (75)
- Structures of NS5 Methyltransferase from Zika Virus (2016) (73)
- Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission (2022) (73)
- Threonine 157 of Influenza Virus PA Polymerase Subunit Modulates RNA Replication in Infectious Viruses (2003) (72)
- Antiviral Response in Pandemic Influenza Viruses (2006) (72)
- Exponential enhancement of oncolytic vesicular stomatitis virus potency by vector-mediated suppression of inflammatory responses in vivo. (2008) (72)
- Thogoto virus ML protein suppresses IRF3 function. (2005) (72)
- Functional Landscape of SARS-CoV-2 Cellular Restriction (2020) (71)
- Lack of Essential Role of NF-κB p50, RelA, and cRel Subunits in Virus-Induced Type 1 IFN Expression1 (2007) (71)
- Identification and characterization of viral antagonists of type I interferon in negative-strand RNA viruses. (2004) (70)
- Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor. (2011) (70)
- Syncytia Induction Enhances the Oncolytic Potential of Vesicular Stomatitis Virus in Virotherapy for Cancer (2004) (70)
- Synergistic drug combination effectively blocks Ebola virus infection (2017) (70)
- The functional impairment of natural killer cells during influenza virus infection (2009) (70)
- Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus (1994) (70)
- Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in Ferrets (2015) (70)
- Recombinant IgA Is Sufficient To Prevent Influenza Virus Transmission in Guinea Pigs (2013) (70)
- Experimental Infection of Pigs with the Human 1918 Pandemic Influenza Virus (2009) (69)
- Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells (2009) (69)
- The NS1 Protein of the 1918 Pandemic Influenza Virus Blocks Host Interferon and Lipid Metabolism Pathways (2009) (69)
- Interferon resistance promotes oncolysis by influenza virus NS1‐deletion mutants (2004) (69)
- Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses (2012) (68)
- Mutations in the NS1 C-terminal tail do not enhance replication or virulence of the 2009 pandemic H1N1 influenza A virus (2010) (67)
- H7N9 influenza viruses interact preferentially with α2,3-linked sialic acids and bind weakly to α2,6-linked sialic acids. (2013) (67)
- Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication (2017) (67)
- DNA immunization of newborn mice with a plasmid-expressing nucleoprotein of influenza virus. (1996) (66)
- Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Potential Target Antigens and Critical Aspects for a Universal Influenza Vaccine. (2018) (66)
- Glycine 184 in Nonstructural Protein NS1 Determines the Virulence of Influenza A Virus Strain PR8 without Affecting the Host Interferon Response (2010) (66)
- Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate (2020) (66)
- Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes (2016) (66)
- Protection against Lethal Influenza with a Viral Mimic (2013) (66)
- An enzymatic virus-like particle assay for sensitive detection of virus entry. (2010) (66)
- Influenza vaccines: present and future. (2002) (66)
- One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge (2014) (66)
- Characterization of a mitochondrial-targeting signal in the PB2 protein of influenza viruses. (2006) (65)
- Avian influenza A H10N8—a virus on the verge? (2014) (64)
- Influenza B and C Virus NEP (NS2) Proteins Possess Nuclear Export Activities (2001) (64)
- A mouse cell-adapted NS4B mutation attenuates West Nile virus RNA synthesis. (2007) (63)
- The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells (2016) (63)
- A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus. (2008) (63)
- Influenza virus still surprises. (2002) (62)
- The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters (2021) (62)
- Increased Viral Loads and Exacerbated Innate Host Responses in Aged Macaques Infected with the 2009 Pandemic H1N1 Influenza A Virus (2012) (61)
- Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways (2013) (61)
- Live‐attenuated influenza viruses as delivery vectors for Chlamydia vaccines (2007) (60)
- Influenza A Virus RNA Polymerase Has the Ability To Stutter at the Polyadenylation Site of a Viral RNA Template during RNA Replication (1999) (60)
- Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses. (2009) (60)
- A Single Amino Acid Substitution in the Novel H7N9 Influenza A Virus NS1 Protein Increases CPSF30 Binding and Virulence (2014) (59)
- Divergent H7 Immunogens Offer Protection from H7N9 Virus Challenge (2014) (59)
- Negative regulation of NF-κB activity by brain-specific TRIpartite Motif protein 9 (2014) (59)
- Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection. (2000) (59)
- Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer. (2004) (58)
- Differential recognition of viral RNA by RIG-I (2011) (58)
- Strong interferon-inducing capacity of a highly virulent variant of influenza A virus strain PR8 with deletions in the NS1 gene. (2009) (58)
- Attenuation of Influenza A Virus mRNA Levels by Promoter Mutations (1998) (58)
- Defining the risk of SARS-CoV-2 variants on immune protection (2022) (58)
- Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins. (2005) (57)
- Immunization with Live Attenuated Influenza Viruses That Express Altered NS1 Proteins Results in Potent and Protective Memory CD8+ T-Cell Responses (2009) (57)
- Rescue of Influenza A Virus from Recombinant DNA (1999) (57)
- Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice (2019) (57)
- COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms (2020) (57)
- Induction of Cross-Reactive Antibodies to Novel H7N9 Influenza Virus by Recombinant Newcastle Disease Virus Expressing a North American Lineage H7 Subtype Hemagglutinin (2013) (57)
- Functional landscape of SARS-CoV-2 cellular restriction (2021) (57)
- Oncolysis of hepatic metastasis of colorectal cancer by recombinant vesicular stomatitis virus in immune-competent mice. (2003) (56)
- Pandemic H1N1 Influenza Isolated from Free-Ranging Northern Elephant Seals in 2010 off the Central California Coast (2013) (56)
- H7N9 influenza virus neutralizing antibodies that possess few somatic mutations. (2016) (56)
- Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses (2012) (56)
- Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion (2017) (55)
- Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children. (2014) (55)
- Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines. (2008) (55)
- N-Glycolylneuraminic Acid as a Receptor for Influenza A Viruses (2019) (55)
- NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets. (2010) (54)
- Viral reassortment and transmission after co-infection of pigs with classical H1N1 and triple-reassortant H3N2 swine influenza viruses (2010) (54)
- mTOR/p70S6K signaling distinguishes routine, maintenance-level autophagy from autophagic cell death during influenza A infection. (2014) (54)
- Current Status of COVID‐19 (Pre)Clinical Vaccine Development (2020) (54)
- Influenza B Virus Ribonucleoprotein Is a Potent Activator of the Antiviral Kinase PKR (2009) (53)
- Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants. (1999) (53)
- Paramyxovirus V Proteins Interact with the RIG-I/TRIM25 Regulatory Complex and Inhibit RIG-I Signaling (2018) (52)
- Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear export (2012) (52)
- Loss of IL-7R and IL-15R Expression Is Associated with Disappearance of Memory T Cells in Respiratory Tract following Influenza Infection1 (2008) (52)
- Antagonism of type I interferon by flaviviruses. (2017) (52)
- Zika Virus Alters DNA Methylation of Neural Genes in an Organoid Model of the Developing Human Brain (2018) (51)
- Insertion of a GFP Reporter Gene in Influenza Virus (2013) (50)
- Innate Immune Response to Influenza Virus at Single-Cell Resolution in Human Epithelial Cells Revealed Paracrine Induction of Interferon Lambda 1 (2019) (50)
- Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses (2015) (50)
- Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation. (2009) (49)
- The cytoplasmic tail of the neuraminidase protein of influenza A virus does not play an important role in the packaging of this protein into viral envelopes. (1995) (49)
- TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation (2021) (49)
- Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection (2020) (48)
- RIG-I Detects mRNA of Intracellular Salmonella enterica Serovar Typhimurium during Bacterial Infection (2014) (48)
- Development of novel influenza virus vaccines and vectors. (1997) (48)
- Pause on avian flu transmission studies (2012) (48)
- A Transient Homotypic Interaction Model for the Influenza A Virus NS1 Protein Effector Domain (2011) (47)
- Interactive Big Data Resource to Elucidate Human Immune Pathways and Diseases. (2015) (47)
- What can we learn from reconstructing the extinct 1918 pandemic influenza virus? (2006) (47)
- SARM Is Required for Neuronal Injury and Cytokine Production in Response to Central Nervous System Viral Infection (2013) (47)
- Antiviral Role of IFITM Proteins in African Swine Fever Virus Infection (2016) (47)
- Co-regulatory activity of hnRNP K and NS1-BP in influenza and human mRNA splicing (2018) (46)
- A Chimeric Influenza Virus Expressing an Epitope of Outer Membrane Protein F of Pseudomonas aeruginosa Affords Protection against Challenge with P. aeruginosa in a Murine Model of Chronic Pulmonary Infection (1998) (46)
- A Reassortment-Incompetent Live Attenuated Influenza Virus Vaccine for Protection against Pandemic Virus Strains (2011) (46)
- Transcriptome Analysis of Infected and Bystander Type 2 Alveolar Epithelial Cells during Influenza A Virus Infection Reveals In Vivo Wnt Pathway Downregulation (2018) (46)
- Induction of Protective Immunity against Malaria by Priming-Boosting Immunization with Recombinant Cold-Adapted Influenza and Modified Vaccinia Ankara Viruses Expressing a CD8+-T-Cell Epitope Derived from the Circumsporozoite Protein of Plasmodium yoelii (2003) (45)
- Apical Budding of a Recombinant Influenza A Virus Expressing a Hemagglutinin Protein with a Basolateral Localization Signal (2002) (45)
- Murine Coronavirus Delays Expression of a Subset of Interferon-Stimulated Genes (2010) (45)
- Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response (2014) (45)
- A Common Polymorphism in the Caspase Recruitment Domain of RIG-I Modifies the Innate Immune Response of Human Dendritic Cells (2010) (45)
- 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales (2021) (44)
- Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses (2020) (44)
- Functional Genomic and Serological Analysis of the Protective Immune Response Resulting from Vaccination of Macaques with an NS1-Truncated Influenza Virus (2007) (44)
- Synthetically derived bat influenza A-like viruses reveal a cell type- but not species-specific tropism (2016) (44)
- Functional Genomic and Serological Analysis of the Protective Immune Response Resulting from Vaccination of Macaques with an NS1-Truncated Influenza Virus (2007) (44)
- The Nucleoprotein of Newly Emerged H7N9 Influenza A Virus Harbors a Unique Motif Conferring Resistance to Antiviral Human MxA (2014) (44)
- Newcastle Disease Virus Expressing a Dendritic Cell-Targeted HIV Gag Protein Induces a Potent Gag-Specific Immune Response in Mice (2010) (44)
- Lessons learned from reconstructing the 1918 influenza pandemic. (2006) (44)
- Genetic Requirement for Hemagglutinin Glycosylation and Its Implications for Influenza A H1N1 Virus Evolution (2013) (44)
- Mucosal Polyinosinic-Polycytidylic Acid Improves Protection Elicited by Replicating Influenza Vaccines via Enhanced Dendritic Cell Function and T Cell Immunity (2014) (44)
- The Morphology and Composition of Influenza A Virus Particles Are Not Affected by Low Levels of M1 and M2 Proteins in Infected Cells (2005) (43)
- Activation and regulation of pathogen sensor RIG-I. (2014) (43)
- The RNA Exosome Syncs IAV-RNAPII Transcription to Promote Viral Ribogenesis and Infectivity (2017) (43)
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing (2020) (43)
- Cellular signaling and innate immune responses to RNA virus infections (2009) (42)
- Induction of Cellular Immune Responses to Simian Immunodeficiency Virus Gag by Two Recombinant Negative-Strand RNA Virus Vectors (2004) (42)
- Influenza virus receptor specificity: disease and transmission. (2010) (42)
- Expected and Unexpected Features of the Newly Discovered Bat Influenza A-like Viruses (2015) (41)
- Pause on avian flu transmission research. (2012) (41)
- Transfection-mediated recombination of influenza A virus (1992) (41)
- Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture (2021) (41)
- Evolution of the Hemagglutinin Protein of the New Pandemic H1N1 Influenza Virus: Maintaining Optimal Receptor Binding by Compensatory Substitutions (2013) (41)
- Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model (2019) (40)
- RNase L Targets Distinct Sites in Influenza A Virus RNAs (2014) (40)
- Negative-strand RNA viruses: applications to biotechnology. (1998) (40)
- Chimeric Influenza A Viruses with a Functional Influenza B Virus Neuraminidase or Hemagglutinin (2003) (40)
- Type I interferon imposes a TSG101/ISG15 checkpoint at the Golgi for glycoprotein trafficking during influenza virus infection. (2013) (40)
- Gastrointestinal involvement attenuates COVID-19 severity and mortality (2020) (39)
- Structure and dynamics of the second CARD of human RIG-I provide mechanistic insights into regulation of RIG-I activation. (2012) (39)
- The ETS transcription factor ELF1 regulates a broadly antiviral program distinct from the type I interferon response (2019) (39)
- ISG15 Regulates Peritoneal Macrophages Functionality against Viral Infection (2013) (38)
- Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity (2021) (38)
- Pathogenicity and transmissibility of reassortant H9 influenza viruses with genes from pandemic H1N1 virus. (2012) (38)
- Influenza virus vectors. (1995) (38)
- A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine (2020) (37)
- Influenza Virus Sequence Feature Variant Type Analysis: Evidence of a Role for NS1 in Influenza Virus Host Range Restriction (2012) (37)
- The neuraminidase of bat influenza viruses is not a neuraminidase (2012) (37)
- Macaque Proteome Response to Highly Pathogenic Avian Influenza and 1918 Reassortant Influenza Virus Infections (2010) (37)
- Transmission Studies Resume for Avian Flu (2013) (37)
- Advances and gaps in SARS-CoV-2 infection models (2022) (37)
- Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model (2021) (37)
- The NS1 protein of influenza A virus suppresses interferon-regulated activation of antigen-presentation and immune-proteasome pathways. (2011) (36)
- A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses (2021) (36)
- Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death (2017) (35)
- Influenza virus infection causes global RNAPII termination defects (2018) (35)
- Emergence and Evolution of Novel Reassortant Influenza A Viruses in Canines in Southern China (2018) (35)
- Mechanism of attenuation of a chimeric influenza A/B transfectant virus (1992) (35)
- ISRE-Reporter Mouse Reveals High Basal and Induced Type I IFN Responses in Inflammatory Monocytes (2018) (35)
- A conserved influenza A virus nucleoprotein code controls specific viral genome packaging (2016) (35)
- Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus (2010) (34)
- Experimental re-infected cats do not transmit SARS-CoV-2 (2021) (34)
- RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus (2015) (34)
- Qualitatively Different Memory CD8+ T Cells Are Generated after Lymphocytic Choriomeningitis Virus and Influenza Virus Infections (2010) (34)
- Memory CD8+ T Cell Responses Expand When Antigen Presentation Overcomes T Cell Self-Regulation1 (2008) (34)
- Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection (2017) (34)
- The neuraminidase and matrix genes of the 2009 pandemic influenza H1N1 virus cooperate functionally to facilitate efficient replication and transmissibility in pigs. (2012) (34)
- Broadly neutralizing antibodies target a haemagglutinin anchor epitope (2021) (34)
- Innate immune sensor LGP2 is cleaved by the Leader protease of foot-and-mouth disease virus (2018) (34)
- Proteins of Newcastle disease virus envelope: interaction between the outer hemagglutinin-neuraminidase glycoprotein and the inner non-glycosylated matrix protein. (1989) (33)
- Taxol increases the amount and T cell activating ability of self-immune stimulatory multimolecular complexes found in ovarian cancer cells. (2007) (33)
- Strain-Specific Contribution of NS1-Activated Phosphoinositide 3-Kinase Signaling to Influenza A Virus Replication and Virulence (2012) (33)
- The NS1 protein: A master regulator of host and viral functions (2013) (33)
- Gain-of-Function Experiments on H7N9 (2013) (33)
- A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners. (2020) (33)
- Host Modulators of H1N1 Cytopathogenicity (2012) (33)
- Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model (2017) (32)
- Contribution of Double-Stranded RNA and CPSF30 Binding Domains of Influenza Virus NS1 to the Inhibition of Type I Interferon Production and Activation of Human Dendritic Cells (2012) (32)
- A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine (2020) (32)
- Pause on Avian Flu Transmission Research (2012) (32)
- Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancer. (1998) (32)
- A multinational Delphi consensus to end the COVID-19 public health threat (2022) (31)
- A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners (2020) (31)
- Vicious circle: systemic autoreactivity in Ro52/TRIM21-deficient mice (2009) (31)
- Cutting Edge: A Potent Adjuvant Effect of Ligand to Receptor Activator of NF-κB Gene for Inducing Antigen-Specific CD8+ T Cell Response by DNA and Viral Vector Vaccination 1 (2003) (31)
- Infection and transmission of ancestral SARS-CoV-2 and its alpha variant in pregnant white-tailed deer (2021) (30)
- ISG15 Is Counteracted by Vaccinia Virus E3 Protein and Controls the Proinflammatory Response against Viral Infection (2013) (30)
- Novel vaccine strategies against emerging viruses (2013) (30)
- IRF 3 and IRF 7 Phosphorylation in Virus-infected Cells Does Not Require Double-stranded RNA-dependent Protein Kinase R or I k B Kinase but Is Blocked by Vaccinia Virus E 3 L Protein * (2001) (30)
- OTUB1 is a key regulator of RIG-I dependent immune signalling and is targeted for proteasomal degradation by influenza A NS1 (2019) (30)
- Passenger mutations confound phenotypes of SARM1-deficient mice (2019) (30)
- Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice (2019) (30)
- Novel triple-reassortant influenza viruses in pigs, Guangxi, China (2018) (29)
- 17β-estradiol protects primary macrophages against HIV infection through induction of interferon-alpha. (2014) (29)
- Packaging of the Influenza Virus Genome Is Governed by a Plastic Network of RNA- and Nucleoprotein-Mediated Interactions (2018) (29)
- Mutations to PB2 and NP Proteins of an Avian Influenza Virus Combine To Confer Efficient Growth in Primary Human Respiratory Cells (2014) (29)
- Bat influenza viruses transmit among bats but are poorly adapted to non-bat species (2019) (29)
- Structural Basis for Influenza Virus NS1 Protein Block of mRNA Nuclear Export (2019) (29)
- Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge. (2016) (29)
- 5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication (2010) (29)
- Protective Cellular Immunity Against Influenza Virus Induced by Plasmid Inoculation of Newborn Mice (1998) (29)
- Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-Mediated Immune Response in Ferrets following Influenza Virus Infection (2016) (29)
- An ultra-high affinity synthetic nanobody blocks SARS-CoV-2 infection by locking Spike 1 into an inactive conformation 2 (2020) (29)
- SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice (2021) (29)
- An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation (2020) (29)
- Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants. (2003) (29)
- Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge. (2004) (28)
- Distinct Patterns of B-Cell Activation and Priming by Natural Influenza Virus Infection Versus Inactivated Influenza Vaccination (2014) (28)
- Activation of Tumor Antigen-Specific Cytotoxic T Lymphocytes (CTLs) by Human Dendritic Cells Infected with an Attenuated Influenza A Virus Expressing a CTL Epitope Derived from the HER-2/neu Proto-Oncogene (2003) (28)
- Contribution of NS1 Effector Domain Dimerization to Influenza A Virus Replication and Virulence (2012) (28)
- Identification of Small Molecules with Type I Interferon Inducing Properties by High-Throughput Screening (2012) (28)
- Human Dendritic Cell Response Signatures Distinguish 1918, Pandemic, and Seasonal H1N1 Influenza Viruses (2015) (28)
- Influenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs (2020) (28)
- Virus‐induced autophagic degradation of STAT2 as a mechanism for interferon signaling blockade (2019) (27)
- The therapeutic effect of death: Newcastle disease virus and its antitumor potential. (2015) (27)
- Infection and transmission of ancestral SARS-CoV-2 and its alpha variant in pregnant white-tailed deer (2021) (27)
- Prostate Tumor Cells Infected with a Recombinant Influenza Virus Expressing a Truncated NS1 Protein Activate Cytolytic CD8+ Cells To Recognize Noninfected Tumor Cells (2006) (27)
- Tumor Suppressor Cylindromatosis (CYLD) Controls HIV Transcription in an NF-κB-Dependent Manner (2014) (26)
- COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms (2021) (26)
- Antibody Immunological Imprinting on COVID-19 Patients (2020) (26)
- Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccines. (2014) (26)
- Structural basis for STAT2 suppression by flavivirus NS5 (2020) (26)
- Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine (2021) (26)
- Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant (2021) (26)
- Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors. (2018) (25)
- Modifications of the PSAP region of the matrix protein lead to attenuation of vesicular stomatitis virus in vitro and in vivo. (2007) (25)
- Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model (2020) (25)
- Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression (2021) (25)
- Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice. (2000) (24)
- Nirmatrelvir, Molnupiravir, and Remdesivir maintain potent in vitro activity against the SARS-CoV-2 Omicron variant (2022) (24)
- HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3 (2015) (24)
- Major Histocompatibility Complex Class II Expression and Hemagglutinin Subtype Influence the Infectivity of Type A Influenza Virus for Respiratory Dendritic Cells (2011) (23)
- Immunologic Characterization of a Rhesus Macaque H1N1 Challenge Model for Candidate Influenza Virus Vaccine Assessment (2014) (23)
- Mapping of the RNA promoter of Newcastle disease virus. (2005) (23)
- Cross-presenting CD 103 + dendritic cells are protected from influenza virus infection (2012) (23)
- Systems-based Analysis of RIG-I-dependent Signaling Identifies KHSRP as an Inhibitor of RIG-I Receptor Activation (2017) (23)
- miR-122 is more than a shield for the hepatitis C virus genome (2013) (23)
- Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs (2021) (22)
- Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay. (2020) (22)
- Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus (2017) (22)
- Characterizing Emerging Canine H3 Influenza Viruses (2020) (22)
- Accumulation of CD11b+Gr-1+ cells in the lung, blood and bone marrow of mice infected with highly pathogenic H5N1 and H1N1 influenza viruses (2013) (22)
- Turkey versus guinea pig red blood cells: hemagglutination differences alter hemagglutination inhibition responses against influenza A/H1N1. (2014) (22)
- Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts (2019) (22)
- COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models (2021) (22)
- Hybrid Gene Origination Creates Human-Virus Chimeric Proteins during Infection (2020) (21)
- Influenza Vaccines: A Moving Interdisciplinary Field (2014) (21)
- North American Triple Reassortant and Eurasian H1N1 Swine Influenza Viruses Do Not Readily Reassort to Generate a 2009 Pandemic H1N1-Like Virus (2014) (21)
- Sequence analysis and receptor specificity of the hemagglutinin of a recent influenza H2N2 virus isolated from chicken in North America (2006) (20)
- Residue Y161 of Influenza Virus Hemagglutinin Is Involved in Viral Recognition of Sialylated Complexes from Different Hosts (2012) (20)
- Functional Characterization and Direct Comparison of Influenza A, B, C, and D NS1 Proteins in vitro and in vivo (2019) (20)
- Gut microbiota manipulation during the prepubertal period shapes behavioral abnormalities in a mouse neurodevelopmental disorder model (2020) (20)
- Influenza Virus NS1 Protein-RNA Interactome Reveals Intron Targeting (2018) (20)
- Inactivated influenza virus vaccines: the future of TIV and QIV. (2017) (20)
- Is It Possible to Develop a “Universal” Influenza Virus Vaccine? Toward a Universal Influenza Virus Vaccine: Potential Target Antigens and Critical Aspects for Vaccine Development (2017) (20)
- Antitumor properties of influenza virus vectors. (2000) (20)
- Rescue of recombinant Newcastle disease virus from cDNA. (2013) (20)
- Induction of immunological memory in baboons primed with DNA vaccine as neonates. (2001) (20)
- Protection against influenza infection requires early recognition by inflammatory dendritic cells through C-type lectin receptor SIGN-R1 (2019) (20)
- Human interactome of the influenza B virus NS1 protein (2017) (20)
- Attenuated Influenza Virus Construct with Enhanced Hemagglutinin Protein Expression (2012) (20)
- STAT2 signaling and dengue virus infection (2014) (20)
- A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin Protein (2014) (20)
- Enhancement of the Proapoptotic Properties of Newcastle Disease Virus Promotes Tumor Remission in Syngeneic Murine Cancer Models (2015) (20)
- Induction of Type I Interferon Secretion through Recombinant Newcastle Disease Virus Expressing Measles Virus Hemagglutinin Stimulates Antibody Secretion in the Presence of Maternal Antibodies (2010) (19)
- Against the clock towards new Ebola virus therapies. (2015) (19)
- Learning from our foes: a novel vaccine concept for influenza virus. (1999) (19)
- Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA. (2017) (19)
- Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19 (2022) (19)
- Moving from Empirical to Rational Vaccine Design in the ‘Omics’ Era (2019) (19)
- Attacking the flu: New prospects for the rational design of antivirals (2009) (19)
- Limited extent and consequences of pancreatic SARS-CoV-2 infection (2022) (19)
- 2 methylate or not 2 methylate: viral evasion of the type I interferon response (2011) (19)
- H5N1 virus: Transmission studies resume for avian flu (2013) (18)
- Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus Tropism (2019) (18)
- A novel high-throughput cell-based method for integrated quantification of type I interferons and in vitro screening of immunostimulatory RNA drug delivery. (2009) (18)
- Model of influenza A virus infection: dynamics of viral antagonism and innate immune response. (2014) (18)
- Differential Requirement for the IKKβ/NF-κB Signaling Module in Regulating TLR- versus RLR-Induced Type 1 IFN Expression in Dendritic Cells (2014) (18)
- A Novel Paramyxovirus? (2005) (17)
- Fusion between Newcastle disease virus and erythrocyte ghosts using octadecyl Rhodamine B fluorescence assay produces dequenching curves that fit the sum of two exponentials. (1994) (17)
- The Pause on Avian H5N1 Influenza Virus Transmission Research Should Be Ended (2012) (17)
- Activity of influenza C virus O-acetylesterase with O-acetyl-containing compounds. (1991) (17)
- Increased influenza A virus sialidase activity with N-acetyl-9-O-acetylneuraminic acid-containing substrates resulting from influenza C virus O-acetylesterase action☆ (1992) (17)
- Chimeric influenza viruses incorporating epitopes of outer membrane protein F as a vaccine against pulmonary infection with Pseudomonas aeruginosa. (1997) (17)
- Sensing RNA virus infections. (2007) (17)
- Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation (2021) (17)
- Mutation of Neuraminidase Cysteine Residues Yields Temperature-Sensitive Influenza Viruses (1999) (17)
- Structural–functional interactions of NS1-BP protein with the splicing and mRNA export machineries for viral and host gene expression (2018) (16)
- Coronavirus disease 2019 (COVID-19) hospitalized patients with acute kidney injury treated with acute peritoneal dialysis do not have infectious peritoneal dialysis effluent (2020) (16)
- Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses (2013) (16)
- Delivery of Chlamydia vaccines (2005) (16)
- Single-cell analysis of early antiviral gene expression reveals a determinant of stochastic IFNB1 expression (2017) (16)
- TAP dysfunction in dendritic cells enables non-canonical cross-presentation for T cell priming (2021) (16)
- Broad Spectrum Inhibitor of Influenza A and B Viruses Targeting the Viral Nucleoprotein. (2018) (16)
- ATPase-Driven Oligomerization of RIG-I on RNA Allows Optimal Activation of Type-I Interferon (2013) (16)
- Novel Bat Influenza Virus NS1 Proteins Bind Double-Stranded RNA and Antagonize Host Innate Immunity (2015) (16)
- Development and Characterization of a Highly Specific and Sensitive SYBR Green Reverse Transcriptase PCR Assay for Detection of the 2009 Pandemic H1N1 Influenza Virus on the Basis of Sequence Signatures (2010) (16)
- PKR is not required for interferon-γ inhibition of VSV replication in neurons (2003) (15)
- Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity (2021) (15)
- COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models (2021) (15)
- Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion (2020) (15)
- Recombinant Influenza A Viruses with Enhanced Levels of PB1 and PA Viral Protein Expression (2012) (15)
- A Genome-Wide CRISPR-Cas9 Screen Reveals the Requirement of Host Cell Sulfation for Schmallenberg Virus Infection (2020) (15)
- Restriction factor compendium for influenza A virus reveals a mechanism for evasion of autophagy (2021) (15)
- SARS-CoV-2 variants of concern have acquired mutations associated with an increased spike cleavage (2021) (15)
- Unanchored ubiquitin in virus uncoating (2014) (15)
- Open Science Discovery of Potent Non-Covalent SARS-CoV-2 Main Protease Inhibitors (2023) (15)
- Host-Range Restriction of Vaccinia Virus E3L Deletion Mutant Can Be Overcome In Vitro, but Not In Vivo, by Expression of the Influenza Virus NS1 Protein (2011) (15)
- Infection in Health Personnel with High and Low Levels of Exposure in a Hospital Setting during the H1N1 2009 Influenza A Pandemic (2016) (14)
- Mouse Dendritic Cell (DC) Influenza Virus Infectivity Is Much Lower than That for Human DCs and Is Hemagglutinin Subtype Dependent (2012) (14)
- The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease (2011) (14)
- Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19 (2020) (14)
- Influenza A viruses and PI3K (2012) (14)
- Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico (2022) (14)
- Prothymosin α variants isolated from CD8+ T cells and cervicovaginal fluid suppress HIV-1 replication through type I interferon induction. (2015) (14)
- Comparison of biological and physical properties of human and animal A(H1N1) influenza viruses. (1989) (14)
- Effect of Cholecalciferol Supplementation on Inflammation and Cellular Alloimmunity in Hemodialysis Patients: Data from a Randomized Controlled Pilot Trial (2014) (14)
- Transfectant influenza viruses as antigen delivery vectors. (2000) (14)
- TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines (2019) (13)
- In Vivo Ligands of MDA 5 and RIGI in Measles Virus-Infected Cells (2014) (13)
- Mapping of the interaction domains of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein. (2015) (13)
- Lessons from Lipids in the Fight against Influenza (2013) (13)
- Introduction of foreign sequences into the genome of influenza A virus. (1994) (13)
- Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients (2020) (12)
- SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses (2018) (12)
- The makings of a killer (2002) (12)
- Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultra-violet C (UVC) irradiation device (2020) (12)
- Interference of viral effector proteins with chromatin, transcription, and the epigenome. (2015) (12)
- Mice Lacking the ISG 15 E 1 Enzyme UbE 1 L Demonstrate Increased Susceptibility to both Mouse-Adapted and Non-Mouse-Adapted Influenza B Virus Infection (2008) (12)
- Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19 (2021) (12)
- Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial (2022) (12)
- H5N1, a wealth of knowledge to improve pandemic preparedness. (2013) (12)
- FACS-Mediated Isolation of Neuronal Cell Populations From Virus-Infected Human Embryonic Stem Cell-Derived Cerebral Organoid Cultures. (2018) (12)
- Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models (2022) (12)
- 1918 and 2009 H1N1 influenza viruses are not pathogenic in birds. (2010) (12)
- Characterization of swine-origin H1N1 canine influenza viruses (2019) (12)
- Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model (2021) (11)
- Specific Mutations in the PB2 Protein of Influenza A Virus Compensate for the Lack of Efficient Interferon Antagonism of the NS1 Protein of Bat Influenza A-Like Viruses (2018) (11)
- Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope Protein (2019) (11)
- A RIG-I 2CARD-MAVS200 Chimeric Protein Reconstitutes IFN-β Induction and Antiviral Response in Models Deficient in Type I IFN Response (2015) (11)
- Corrigendum: Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity (2015) (11)
- Working Safely with H5N1 Viruses (2012) (11)
- The influenza virus protein PB 1F 2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein VARGA (2017) (11)
- Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate (2020) (11)
- An Enzymatic Assay for Detection of Viral Entry (2011) (11)
- Influenza Virus Adaptation PB 2627 K Modulates Nucleocapsid Inhibition by the Pathogen Sensor RIGI Graphical (2015) (11)
- Influenza A(H1N1)pdm09 virus infection in marine mammals in California (2013) (11)
- A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies (2018) (11)
- Autoantibodies against type I IFNs in patients with critical influenza pneumonia (2022) (11)
- Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells (2007) (10)
- Physiology of cardiomyocyte injury in COVID-19 (2020) (10)
- Zika virus NS3 protease induces bone morphogenetic protein-dependent brain calcification in human fetuses (2020) (10)
- African Swine Fever Virus Induces STAT1 and STAT2 Degradation to Counteract IFN-I Signaling (2021) (10)
- Differential Modulation of Innate Immune Responses in Human Primary Cells by Influenza A Viruses Carrying Human or Avian Nonstructural Protein 1 (2019) (10)
- Induction and Evasion of Type-I Interferon Responses during Influenza A Virus Infection. (2020) (10)
- A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats. (2018) (10)
- Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam (2022) (9)
- Erratum to: Induction of type I interferon by RNA viruses: cellular receptors and their substrates (2011) (9)
- Viral Fitness Landscapes in Diverse Host Species Reveal Multiple Evolutionary Lines for the NS1 Gene of Influenza A Viruses (2019) (9)
- PKR is not required for interferon-gamma inhibition of VSV replication in neurons. (2003) (9)
- Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera (2022) (9)
- Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA. (2022) (9)
- Functional Effects of Cardiomyocyte Injury in COVID-19 (2021) (9)
- Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats (2021) (9)
- Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine** (9)
- Chemical intervention of influenza virus mRNA nuclear export (2020) (9)
- Mathematical analysis of a mouse experiment suggests little role for resource depletion in controlling influenza infection within host (2017) (9)
- Antiviral innate immunity through the lens of systems biology. (2016) (9)
- Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial (2021) (8)
- Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization. (2021) (8)
- Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice (2022) (8)
- Phospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2 (2021) (8)
- Host immune response–inspired development of the influenza vaccine (2020) (8)
- Analysis of the Evolution of Pandemic Influenza A(H1N1) Virus Neuraminidase Reveals Entanglement of Different Phenotypic Characteristics (2021) (8)
- 2022 taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales (2022) (8)
- Susceptibility of sheep to experimental co-infection with the ancestral lineage of SARS-CoV-2 and its alpha variant (2022) (8)
- Influenza B virus reverse genetic backbones with improved growth properties in the EB66® cell line as basis for vaccine seed virus generation. (2018) (8)
- Poly-ADP Ribosyl Polymerase 1 (PARP1) Regulates Influenza A Virus Polymerase. (2019) (8)
- Correction: ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA (2016) (8)
- ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2 (2021) (8)
- Varying Inoculum Dose to Assess the Roles of the Immune Response and Target Cell Depletion by the Pathogen in Control of Acute Viral Infections (2020) (8)
- Susceptibility of sheep to experimental co-infection with the ancestral lineage of SARS-CoV-2 and its alpha variant (2021) (7)
- Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice (2021) (7)
- The RNA helicase DHX16 recognizes specific viral RNA to trigger RIG-I-dependent innate antiviral immunity (2022) (7)
- Substitutions T200A and E227A in the Hemagglutinin of Pandemic 2009 Influenza A Virus Increase Lethality but Decrease Transmission (2013) (7)
- Recombinant influenza virus vectors (2007) (7)
- La Piedad Michoacán Mexico Virus V protein antagonizes type I interferon response by binding STAT2 protein and preventing STATs nuclear translocation. (2016) (7)
- Systems vaccinology informs influenza vaccine immunogenicity (2016) (7)
- Gain-of-function experiments on H7N9. (2013) (7)
- Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal models (2020) (7)
- Regulation of PURA gene transcription by three promoters generating distinctly spliced 5-prime leaders: a novel means of fine control over tissue specificity and viral signals (2010) (7)
- Hepatitis C Virus Drugs Simeprevir and Grazoprevir Synergize with Remdesivir to Suppress SARS-CoV-2 Replication in Cell Culture (2020) (7)
- Cytopathogenesis of Vesicular Stomatitis Virus Is Regulated by the PSAP Motif of M Protein in a Species-Dependent Manner (2012) (7)
- Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies (2020) (6)
- A HER2-Displaying Virus-Like Particle Vaccine Protects from Challenge with Mammary Carcinoma Cells in a Mouse Model (2019) (6)
- Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses (2020) (6)
- Active opioid use does not attenuate the humoral responses to inactivated influenza vaccine. (2016) (6)
- Overcoming NS1-mediated immune antagonism involves both interferon-dependent and independent mechanisms. (2013) (6)
- IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization (2021) (6)
- Influenza virus NS1- C/EBPβ gene regulatory complex inhibits RIG-I transcription. (2020) (6)
- Predicting the pathogenesis of influenza from genomic response: a step toward early diagnosis (2011) (6)
- Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants (2022) (6)
- The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters (2022) (6)
- Evaluation and validation of an RT‐PCR assay for specific detection of monkeypox virus (MPXV) (2022) (6)
- A novel SUMOylation site in the influenza a virus NS1 protein identified with a highly sensitive FRET assay. (2020) (6)
- Enzymatic glycosidase activities in experimental obesity. (1992) (6)
- Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells (2019) (6)
- A Newcastle disease virus-vector expressing a prefusion-stabilized spike protein of SARS-CoV-2 induces protective immune responses against prototype virus and variants of concern in mice and hamsters (2021) (6)
- Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer (2022) (5)
- Influenza Virus Infects and Depletes Activated Adaptive Immune Responders (2021) (5)
- Discovery of a SARS-CoV-2 Broadly-Acting Neutralizing Antibody with Activity against Omicron and Omicron + R346K Variants (2022) (5)
- rVSV(M (cid:2) 51)-M3 Is an Effective and Safe Oncolytic Virus for Cancer Therapy (2008) (5)
- Interferon Antagonists of Influenza Viruses (2005) (5)
- In memoriam--Richard M. Elliott (1954-2015). (2015) (5)
- Obesity and Metabolic Dysregulation in Children Provide Protective Influenza Vaccine Responses (2022) (5)
- Expression of the Ebola Virus VP24 Protein Compromises the Integrity of the Nuclear Envelope and Induces a Laminopathy-Like Cellular Phenotype (2021) (5)
- Faculty Opinions recommendation of Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. (2009) (5)
- STAT2 Limits Host Species Specificity of Human Metapneumovirus (2020) (5)
- , AP-1 Transcription Factors Activation of Jun N-Terminal Kinase and The Influenza A Virus NS 1 Protein Inhibits (2002) (5)
- Aryl Sulfonamide Inhibits Entry and Replication of Diverse Influenza Viruses via the Hemagglutinin Protein. (2021) (5)
- Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1 (2021) (5)
- Divergent H 7 Immunogens Offer Protection from H 7 N 9 Virus Challenge (2014) (5)
- Correction to: 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales (2021) (5)
- Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial. (2022) (4)
- In Vivo Replication and Pathogenesis of Vesicular Stomatitis Virus Recombinant M40 Containing Ebola Virus L-Domain Sequences (2012) (4)
- Virology under the Microscope—a Call for Rational Discourse (2023) (4)
- NS-based live attenuated H 1 N 1 pandemic vaccines protect mice and ferrets ZHOU (2017) (4)
- Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultraviolet C (UVC) irradiation device (2021) (4)
- Quantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection. (2010) (4)
- A cross-reactive mouse monoclonal antibody against rhinovirus mediates phagocytosis in vitro (2020) (4)
- Cell biology: Beneficial lessons from viruses (2013) (4)
- A dual vaccine against influenza & Alzheimer's disease failed to enhance anti-β-amyloid antibody responses in mice with pre-existing virus specific memory (2014) (4)
- New data on influenza virus type C confirm its peculiarities as a new genus. (1991) (4)
- Mutations in the NS 1 C-terminal tail do not enhance replication or virulence of the 2009 pandemic H 1 N 1 influenza A virus (2010) (3)
- The origin of the PB1 segment of swine influenza A virus subtype H1N2 determines viral pathogenicity in mice. (2014) (3)
- Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses. (2021) (3)
- Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity (2022) (3)
- Microbiome disturbance and resilience dynamics of the upper respiratory tract in response to influenza A virus infection in analog hosts (2018) (3)
- Host-pathogen interactions. (2010) (3)
- Membrane glycoproteins of Newcastle disease virus: Nucleotide sequence of the hemagglutinin-neuraminidase cloned gene and structure/function relationship of predicted amino acid sequence (2001) (3)
- Host modulators of H 1 N 1 cytopathogenicity WARD (2017) (3)
- Type I and Type II Interferon Antagonism Strategies Used by Paramyxoviridae: Previous and New Discoveries, in Comparison (2022) (3)
- Infectious Influenza Viruses from cDNA-Derived RNA: Reverse Genetics (1993) (3)
- OA01.01 Analysis of Lung Cancer Patients Receiving SARS-CoV-2 Vaccines Revealed a Minority Subset With Poor Antibody Responses Relative to Controls (2021) (3)
- Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single cell RNA sequencing (2021) (3)
- Series Introduction: New directions in vaccine research (2002) (3)
- A High-Resolution Look at Influenza Virus Antigenic Drift. (2016) (3)
- Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis (2022) (3)
- Suppression of innate immunity by orthomyxoviruses. (2009) (3)
- Increased serum N-acetyl-beta-D-glucosaminidase and alpha-D-mannosidase activities in obese subjects. (1992) (3)
- PQBP 1 Is a Proximal Sensor of the cGAS-Dependent Innate Response to HIV-1 Graphical Abstract Highlights (2015) (3)
- Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains (2015) (3)
- Author Correction: Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection (2020) (3)
- Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice (2022) (3)
- Accumulation of CD11b+Gr-1+ cells in the lung, blood and bone marrow of mice infected with highly pathogenic H5N1 and H1N1 influenza viruses (2013) (2)
- TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines (2020) (2)
- Sialidase activity in rimantadine-resistant and -sensitive influenza A viruses. (1990) (2)
- Erratum: Human intracellular ISG15 prevents interferon-α±/β 2 over-amplification and auto-inflammation (Nature 517 (2015) (89-93) 10.1038/nature13801)) (2015) (2)
- Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2/neu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. Divergent roles of IL-2 and IL-15. (2005) (2)
- Development of a Macrophage-Based ADCC Assay (2021) (2)
- Mass Cytometry Defines Virus-Specific CD4+ T Cells in Influenza Vaccination (2020) (2)
- Correction: ISG15 Regulates Peritoneal Macrophages Functionality against Viral Infection (2013) (2)
- Bat pluripotent stem cells reveal unusual entanglement between host and viruses (2022) (2)
- Pandemic Virus Characterization of the Reconstructed 1918 Spanish Influenza (2012) (2)
- Correction: The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells (2017) (2)
- Intrinsic Cellular Defenses (TRIMS) in Modulating Viral Infection and Immunity (2016) (2)
- Common and species-specific molecular signatures, networks, and regulators of influenza virus infection in mice, ferrets, and humans (2022) (2)
- Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine (2020) (2)
- TIV Vaccination Modulates Host Responses to Influenza Virus Infection that Correlate with Protection against Bacterial Superinfection (2019) (2)
- Timing of Influenza Vaccine Response in Patients That Receive Autologous Hematopoietic Cell Transplantation (2017) (2)
- Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes (2021) (2)
- Poly-ADP Ribosyl Polymerase 1 (PARP1) Regulates Influenza A Virus Polymerase (2018) (2)
- Correction: ISG15 Regulates Peritoneal Macrophages Functionality against Viral Infection (2016) (2)
- INFLUENZA VIRUSES (ORTHOMYXOVIRIDAE) | Molecular Biology (1999) (2)
- A Newly Emerged Swine-Origin Influenza A(H3N2) Variant Dampens Host Antiviral Immunity but Induces Potent Inflammasome Activation. (2015) (2)
- STAT2 is a determinant of yellow fever virus host tropism (2015) (2)
- Large library docking for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors (2022) (2)
- Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine (2021) (2)
- Unanchored Lysine48-linked polyubiquitin chains positively regulate the type I IFN-mediated antiviral response (P1391) (2013) (2)
- Corrigendum: Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine (2021) (2)
- Effect of anaesthesia and acute intestinal ischemia on serum beta-N-acetylhexosaminidase activity in rabbit as biological model. (1992) (2)
- Diversity, Replication, Pathogenicity and Cell Biology of Crimean Congo Hemorrhagic Fever Virus (2006) (2)
- Proteomic Identification of Potential Target Proteins of Cathepsin W for Its Development as a Drug Target for Influenza (2022) (2)
- Faculty Opinions recommendation of IFITM3 restricts the morbidity and mortality associated with influenza. (2012) (2)
- Three-stranded antiviral attack (2014) (2)
- Protein‐protein interactions in membranes: A simple practical laboratory class for advanced students of biochemistry and molecular biology (1990) (1)
- Lessons From 1918 (2007) (1)
- Type I IFN promotes pathogenic inflammatory monocyte maturation during H5N1 infection (2022) (1)
- Mechanism ofAttenuation ofaChimeric Influenza A/BTransfectant Virus (1992) (1)
- Editorial overview: Emerging viruses: interspecies transmission (2019) (1)
- Live Visualization of Hemagglutinin Dynamics during Infection by Using a Novel Reporter Influenza A Virus (2020) (1)
- The role of unanchored polyubiquitin chains and the TRIM E3-ubiquitin ligase family of proteins in the innate immune response to influenza virus infection (INM3P.402) (2015) (1)
- Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine (2022) (1)
- Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants (2022) (1)
- Right Ventricular Abnormality in Patients Hospitalized With COVID-19 Infection During Omicron Variant Surge (2022) (1)
- Replication and Mortality in Mice and Neutrophils in Limiting Virus Functional Roles of Alveolar Macrophages Genes from the 1918 Pandemic Virus : Pathogenicity of Influenza Viruses with (2005) (1)
- Virus versus host: modulation of the host α/β interferon pathways by the influenza A virus NS1 protein (2001) (1)
- Newcastle disease virus ( NDV ) expressing the spike protein of SARS-CoV-2 as vaccine candidate 1 2 (2020) (1)
- Increased serum N-acetyl-β-d-glucosaminidase and α-ddd-mannosidase activities in obese subjects (1992) (1)
- drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication (2010) (1)
- Virology under the Microscope—a Call for Rational Discourse (2023) (1)
- Macroautophagy Proteins Control MHC Class I Levels on Dendritic Cells and Shape Anti-viral CD 8 + T Cell Responses Graphical (2016) (1)
- Faculty Opinions recommendation of The LRR and RING domain protein LRSAM1 is an E3 ligase crucial for ubiquitin-dependent autophagy of intracellular Salmonella Typhimurium. (2013) (1)
- Potential applications of influenza A virus vectors as tumor vaccines (2001) (1)
- A Single Amino Acid Substitution in 1918 Influenza Virus Hemagglutinin Changes Receptor Binding Specificity (2005) (1)
- SARS-CoV-2 variants of concern have acquired mutations associated with an 1 increased spike cleavage 2 (2021) (1)
- Profiling Selective Packaging of Host RNA and Viral RNA Modification in SARS-CoV-2 Viral Preparations (2022) (1)
- Discovery of UFO Proteins: Human-Virus Chimeric Proteins Generated During Influenza Virus Infection (2019) (1)
- Evolution of influenza A virus in intensive and free-range swine farms in Spain (2021) (1)
- Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection (2023) (1)
- Changes in a new type of genomic accordion may open the pallets to increased monkeypox transmissibility (2022) (1)
- Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity (2022) (1)
- Virology under the Microscope—a Call for Rational Discourse (2023) (1)
- Influenza Virus mRNA Trafficking Through Host Nuclear Speckles. (2016) (1)
- Interaction between chicken TRIM25 and MDA5 and their role in mediated antiviral activity against IBDV infection (2022) (1)
- 292 p53 Transcriptionally activates IRF9 to enhance antiviral immunity (2008) (1)
- SARS-CoV-2 viral protein ORF3A injures renal tubules by interacting with TRIM59 to induce STAT3 activation (2022) (1)
- A public broadly neutralizing antibody class targets a membrane-proximal anchor epitope of influenza virus hemagglutinin (2021) (1)
- Avian Paramyxovirus 4 Antitumor Activity Leads to Complete Remissions and Long-term Protective Memory in Preclinical Melanoma and Colon Carcinoma Models (2022) (1)
- Global landscape of the host response to SARS-CoV-2 variants reveals viral evolutionary trajectories (2022) (1)
- Generation of a high yield vaccine backbone for influenza B virus in embryonated chicken eggs (2023) (0)
- Immunodominance hierarchy after seasonal influenza vaccination (2022) (0)
- Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia (2023) (0)
- The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio of neutralizing to non-neutralizing antibodies in humans as compared to mRNA vaccines (2022) (0)
- Vaccination modulates pulmonary eosinophil subsets upon breakthrough influenza infection. (2022) (0)
- DependentDCs and Is Hemagglutinin Subtype Infectivity Is Much Lower than That for Mouse Dendritic Cell (DC) Influenza Virus (2014) (0)
- SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules (2022) (0)
- GM swine influenza virus and uses thereof (2005) (0)
- The regulatory factor ELF1 triggers a critical wave of transcription in the antiviral response to type I interferon (2019) (0)
- Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus (2017) (0)
- SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6 (2020) (0)
- Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death (2017) (0)
- Swine flu virus engineered and uses thereof (2005) (0)
- SARS-COV-2 vaccine: current biological targets and considerations (2020) (0)
- Faculty Opinions recommendation of Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. (2010) (0)
- Animal models for COVID-19 (2020) (0)
- Corrigendum: Influenza virus mRNA trafficking through host nuclear speckles (2017) (0)
- P114 Modulation of vaccine-induced T cell immunity by specific adjuvants (2012) (0)
- RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine (2022) (0)
- Attenuated virus with negative polarity chain with altered interferon antagonist activity for use as vaccines and pharmaceuticals (1999) (0)
- Author Correction: SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses (2018) (0)
- Recent strategies to identify broadly neutralizing antibodies against influenza A virus (2009) (0)
- Erratum: Sunwoo, S.-Y. et al. A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies. Vaccines 2018, 6(3), 64 (2018) (0)
- Gut microbiota manipulation during the prepubertal period shapes behavioral abnormalities in a mouse neurodevelopmental disorder model (2020) (0)
- influenza A virus . A plasmid-based reverse genetics system for (1996) (0)
- A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in ferrets (2016) (0)
- Faculty Opinions recommendation of Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. (2008) (0)
- Snatch-and-Grab Inhibitors to Fight the Flu (2019) (0)
- Correction for Eduardo-Correia et al., ISG15 Is Counteracted by Vaccinia Virus E3 Protein and Controls the Proinflammatory Response against Viral Infection (2016) (0)
- Interference of MERS-CoV accessory genes with the innate immune response and their contribution to virulence (2016) (0)
- Tracking the emergence of antigenic variants in influenza A virus epidemics in Brazil (2023) (0)
- Cross‐presentation of Influenza virus vaccine antigens to CD8+ T cells in humanized mice (2008) (0)
- Structure of anti-SARS-CoV-2 Spike nanobody mNb6 (2020) (0)
- Varying Inoculum Dose to Assess the Roles of the Immune Response and Target Cell Depletion by the Pathogen in Control of Acute Viral Infections (2020) (0)
- Influenza: Are We Prepared for a Pandemic? (2005) (0)
- Influenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs (2020) (0)
- Innate Immune Response of Human Recruitment Domain of RIG-I Modifies the A Common Polymorphism in the Caspase (0)
- A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial (2020) (0)
- Author Correction: SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses (2018) (0)
- Retinoic acid-inducible gene I (RIG-I) is essential for activating host cell innate (2022) (0)
- Hepatitis C Virus Protease Inhibitors Suppress Virus Replication and Act Synergistically with the SARS-CoV2 Polymerase Inhibitor Remdesivir (2021) (0)
- Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts (2019) (0)
- The type I interferon system and viruses (2018) (0)
- Faculty Opinions recommendation of Dissolving polymer microneedle patches for influenza vaccination. (2010) (0)
- Understanding memory B cell responses to a chimeric-based universal influenza virus vaccine candidate (2020) (0)
- Experimental Infection of Pigs with the Human 1918 Pandemic Influenza Virus (cid:1) (2009) (0)
- Genomic accordions may hold the key to Monkeypox Clade IIb's increased transmissibility. (2022) (0)
- Antigen presentation (SY4-2) Chairpersons: William Heath, Christian Münz (2010) (0)
- Antigenic Landscape Analysis of Individuals Vaccinated with a Universal Influenza Virus Vaccine Candidate Reveals Induction of Cross-Subtype Immunity (2022) (0)
- Protocol to isolate and assess spike protein cleavage in SARS-CoV-2 variants obtained from clinical COVID-19 samples (2022) (0)
- Faculty Opinions recommendation of Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense. (2010) (0)
- Summary and Perspectives (2009) (0)
- Faculty Opinions recommendation of Direct activation of protein kinases by unanchored polyubiquitin chains. (2009) (0)
- Single cell variability in pro-inflammatory and antiviral gene responses in dendritic cells (2016) (0)
- Faculty Opinions recommendation of The unfolded protein response element IRE1α senses bacterial proteins invading the ER to activate RIG-I and innate immune signaling. (2013) (0)
- Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses (2012) (0)
- Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses (2015) (0)
- Characterizing Emerging Canine H3 Influenza Viruses. (2020) (0)
- Berichtigung: Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine (2021) (0)
- ISRE-Reporter Mouse Rev eals High Basal and Induced Type I IFN Responses in Inflammatory Monocytes Graphical (2018) (0)
- Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2 (2022) (0)
- Increasing intratumoral dendritic cells to potentiate anti-tumor effects of Newcastle disease virus-based immunotherapy (2019) (0)
- Editorial overview: host-microbe interactions: viruses. (2015) (0)
- COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms (2020) (0)
- A multicomponent intranasal adjuvant drives durable humoral, cellular, and mucosal immune responses to SARS-CoV-2 in young and aged mice (2023) (0)
- Infection-permissive immunity against influenza virus provided by vaccination prevents loss of alveolar macrophages and modulates virus-induced cross-reactive cellular immune responses during subsequent influenza infections. (2017) (0)
- HER-2-Nascent Polypeptide Chain Bound on Ribosomes Translating Influenza Virus Proteins Induces Differentiation of CD8+ Cells (2005) (0)
- Structure function characterization of SARS CoV2 proteases for COVID19 antiviral development (2022) (0)
- CS17-5. Arteri- and nairovirus OTU domain-containing proteases target ubiquitin-regulated factors in the RLR-mediated innate immune signaling pathway (2011) (0)
- Structure of a viral OTU domain protease bound to Ubiquitin (2011) (0)
- RNA expression systems of recombinant virus newcastle disease vaccines and corresponspentes. (1999) (0)
- Phylogenetic landscape of Monkeypox Virus (MPV) during the early outbreak in New York City, 2022. (2023) (0)
- Mechanisms of coronavirus pathogenicity and virus-host interactions (2019) (0)
- An infectious bat chimeric influenza virus harboring the entry machinery of a influenza A virus (2014) (0)
- Transmission of Pandemic H1N1 Influenza Virus and Impact of Prior Exposure to Seasonal Strains or Interferon Treatment (cid:1) (2009) (0)
- Cell Host & Microbe Dengue NS 5 Is a Species-Specific (2010) (0)
- Mouse STAT2 is a dengue virus host restriction factor (2009) (0)
- Influenza Pathogenesis: 1918-2009 (2009) (0)
- Abstract S01-02: Assessing vulnerability of patients with lung cancer to SARS-CoV-2 infection based on serological antibody analyses (2021) (0)
- Faculty Opinions recommendation of Antiviral immunity in Drosophila requires systemic RNA interference spread. (2009) (0)
- Human CD1c+ DCs drive the differentiation of CD103+ intraepithelial CD8+ T cells via TGF beta (48.12) (2012) (0)
- Issue Information (2017) (0)
- Influenza virus mRNAs encode determinants for nuclear export via the cellular TREX-2 complex (2023) (0)
- Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry (2018) (0)
- Faculty Opinions recommendation of Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. (2010) (0)
- CS03-4. TRIM proteins regulate the innate immune response (2011) (0)
- Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection (2020) (0)
- Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination (2022) (0)
- Antitumor Properties of Influenza Virus Vectors 1 (2000) (0)
- mice vaccinated with influenza virus vaccines (2016) (0)
- P599 Use of avian influenza genodiagnostics in the Republic of Kazakhstan (2007) (0)
- Faculty Opinions recommendation of A bilirubin-inducible fluorescent protein from eel muscle. (2013) (0)
- PB1-F2 Expression by the 2009 Pandemic H1N1 Influenza Virus Has Minimal Impact on Virulence in Animal Models (cid:1) (2010) (0)
- The Role of a Specific Hemagglutinin Residue as an Indicator of The Evolution Dynamics of Human Influenza A H1N1 Viruses (2014) (0)
- Rift Valley fever virus Gn V5-epitope tagged virus enables identification of UBR4 as a Gn interacting protein that facilitates Rift Valley fever virus production. (2022) (0)
- Structural basis for influenza virus NS1 protein block of mRNA nuclear export (2019) (0)
- Major Histocompatibility Complex Class II Expression and Hemagglutinin Subtype Influence the Infectivity of Type A Influenza Virus for Respiratory Dendritic Cells (cid:1) (2011) (0)
- Influenza Epidemics and Pandemics (2015) (0)
- Nuclear speckle integrity and function require TAO2 kinase (2022) (0)
- ID: 108: Spatial insights in the interaction between the RIG-I like receptor pathway and viral proteins (2015) (0)
- Corrigendum (2007) (0)
- Title : SARS-CoV-2 variants of concern have acquired mutations associated with an 1 increased spike cleavage 2 3 (2021) (0)
- Prostate tumor cells infected with a recombinant influenza virus with truncated NS1 gene NS1 (1-126) activate cytolytic CD8+ cells which recognize non-infected tumors (2004) (0)
- Innate immune responses to dengue infection. (2014) (0)
- Influenza Virus Usurps an Interferon-Induced Translational Program to Promote Viral Replication (2020) (0)
- Pioneers of pathogenesis: past and present. (2011) (0)
- Author Correction: Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection (2020) (0)
- Expression systems recombinant RNA virus and Newcastle disease vaccines (1999) (0)
- Immune Evasion by Influenza Viruses (2009) (0)
- Interferon inducing genetically modified attenuated virus (1999) (0)
- Faculty Opinions recommendation of RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. (2013) (0)
- Mitochondrial antiviral signalling proteins form an intricate three-stranded helical filament that has a central role in the response of cells to viruses. (2014) (0)
- SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses (2018) (0)
- Molecular Insights into the Pathogenesis of Pandemic Influenza: Lessons From 1918 (2005) (0)
- Hepatitis C Virus Drugs Simeprevir And Grazoprevir Synergize with Remdesivir to Suppress SARS-CoV2 Replication (2020) (0)
- Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2 (2022) (0)
- Title Host-Specific NS 5 Ubiquitination Determines Yellow Fever Virus Tropism (2019) (0)
- An Interview with Adolfo Garcia-Sastre, PhD. (2021) (0)
- Contents, Vol. 32, 1991 (1991) (0)
- The Experts Speak: A New Feature in the JICR. (2021) (0)
- Newcastle Disease Virus Expressing a Dendritic Cell-Targeted HIV Gag Protein Induces a Potent Gag-Specific Immune Response in Mice (cid:1) (2011) (0)
- Immunity TRIM 6 Regulates the Type (2014) (0)
- Co-regulatory activity of hnRNP K and NS1-BP in influenza and human mRNA splicing (2018) (0)
- Impact of pre-existing specific influenza antibodies as a determinant of disease severity on influenza virus infected patients: a multicenter observational cohort study (2020) (0)
- Activity of human serum antibodies in a hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay (2020) (0)
- CS08-7. Role for RNase L in the Induction of IFN-β by Influenza A Virus Lacking NS1 (2011) (0)
- New methods and interferon-deficient substrates for virus propagation. (1999) (0)
- Faculty Opinions recommendation of Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. (2011) (0)
- Recognition of HIV-1 Capsid Licenses Innate Immune Response to Viral Infection (2022) (0)
- Bcl-2 Interacting Killer, Bik, Promotes Influenza A Virus Replication and Severity to Flu (2023) (0)
- Chimeric influenza viruses, recombinant DNA molecule, the method for producing an immunogenic formulation chimeric NDV, and method for inducing an immune response to infectious agents both (2006) (0)
- TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO) (2021) (0)
- , Georg Induction of the Antiviral State Transcription Factor Redundancy Ensures (2010) (0)
- Faculty Opinions recommendation of Salmonella transforms follicle-associated epithelial cells into M cells to promote intestinal invasion. (2012) (0)
- Influenza virus infection causes global RNAPII termination defects (2018) (0)
- A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity. (2023) (0)
- PL-15 Modulation of influenza virus replication and virulence by viral-host protein interactions (2008) (0)
- Cytokine Production in Response to Central SARM Is Required for Neuronal Injury and (2013) (0)
- New directions in vaccine research. (2002) (0)
- Influenza virus suppresses the adaptive immune response leaving immune hosts vulnerable to influenza and other respiratory pathogens (2020) (0)
- Faculty Opinions recommendation of Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. (2009) (0)
- Structural basis for STAT2 suppression by NS5. (2020) (0)
- Author Correction: Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus (2018) (0)
- Antiviral Immunity Type I IFN Modulates Innate and Specific (2000) (0)
- Genetically modified swine influenza virus and uses thereof (2005) (0)
- A conserved influenza A virus NP code regulates viral genome packaging (2016) (0)
- Author Correction: Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus (2018) (0)
- Subject Index, Vol. 32, 1991 (1991) (0)
- Faculty Opinions recommendation of A distinct lineage of influenza A virus from bats. (2012) (0)
- The DBA.2 Mouse Is Susceptible to Disease following Infection with a Broad, but Limited, Range of Influenza A and B Viruses (cid:1) (2011) (0)
- Mass Cytometry Defines Virus-Specific CD4 (2020) (0)
- Nairovirus Deubiquitinylating Peptidase (2012) (0)
- Reverse genetic analysis of bat influenza virus harboring the entry machinery of an influenza a virus (2015) (0)
- An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination (2023) (0)
- Issue Information (2014) (0)
- Fr137 FIRST HIGH DIMENSIONAL EXAMINATION OF INTESTINAL BIOPSIES IN PATIENTS WITH COVID-19 (2021) (0)
- ID: 55: Humans with loss-of-function mutations in ISG15 display gain-of-function in anti-viral immunity at the expense of increased susceptibility to mycobacteria and auto-immunity (2015) (0)
- In fl uenza virus mRNA traf fi cking through host nuclear speckles (2017) (0)
- Supplementary Material for: A RIG-I 2CARD-MAVS200 Chimeric Protein Reconstitutes IFN-β Induction and Antiviral Response in Models Deficient in Type I IFN Response (2017) (0)
- Issue Information (2014) (0)
- A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies (2017) (0)
- Faculty Opinions recommendation of 5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. (2009) (0)
- Responses to Influenza A Virus Enhances Innate and Adaptive Immune p53 Serves as a Host Antiviral Factor That (2011) (0)
- Structure of a viral OTU domain protease bound to interferon-stimulated gene 15 (ISG15) (2011) (0)
- An infectious bat chimeric influenza virus harboring the entry machinery of conventional Influenza A virus (2014) (0)
- PP.48 Breakthrough SARS-CoV-2 Infection and COVID-19 Disease Severity in Lung Cancer Patients (2023) (0)
- Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine. (2021) (0)
- The 1997 flu in Hong Kong infected only 18 patients, but killed 6 of them. Now, reverse genetics experiments have pinpointed the NS1 gene as a primary culprit. (2002) (0)
- eIF5A is activated by virus infection or dsRNA and facilitates virus replication through modulation of interferon production (2022) (0)
- Suboptimal influenza vaccination results in higher numbers of pulmonary macrophages upon influenza challenge in mice (2016) (0)
- Subtype Hemagglutinin Expressing a North American Lineage H7 Recombinant Newcastle Disease Virus Novel H7N9 Influenza Virus by Induction of Cross-Reactive Antibodies to (2014) (0)
- Visualization of early RNA replication kinetics of SARS-CoV-2 by using single molecule RNA-FISH (2022) (0)
- Hantaan Virus Nucleocapsid Protein Binds to Importin (cid:2) Proteins and Inhibits Tumor Necrosis Factor Alpha-Induced Activation of Nuclear Factor Kappa B (cid:1) (2008) (0)
- SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6 (2020) (0)
- In vitro reconstruction of the segmented negative-strand RNA viruses (2000) (0)
- Faculty Opinions recommendation of A capsid-encoded PPxY-motif facilitates adenovirus entry. (2010) (0)
- ATPase-driven oligomerization of RIG-I on an RNA ligand allows optimal induction of type I interferon (P1260) (2013) (0)
- P2-298: The novel strategy for generation of effective and safe Alzheimer's disease vaccine based on conventional influenza virus vaccine modified to express Aβ1-11 (2008) (0)
- Short Communication Mutations in the NS1 C-terminal tail do not enhance replication or virulence of the 2009 pandemic H1N1 influenza A virus (2010) (0)
- An intranasal recombinant NDV-BRSV Fopt vaccine is safe and reduces lesion severity in a colostrum-deprived calf model of RSV infection (2022) (0)
- TITLE: An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an 1 inactive conformation 2 (2020) (0)
- Title : 1 Mouse dendritic cell influenza virus infectivity is much 2 lower than for human and is hemagglutinin subtype 3 dependent 4 5 Running title : 6 Influenza infectivity in human and murine DCs 7 8 (2012) (0)
- Erratum: Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation (2015) (0)
- Mucosal delivery of RNA vaccines by Newcastle disease virus vectors (2022) (0)
- Contents Category: Animal Viruses-Negative-strand RNA 4 (2013) (0)
- Human SUMOylation Pathway Is Critical for Influenza B Virus (2022) (0)
- Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences: 356 (1416) (2001) (0)
- Genomics serology to inform therapies and vaccines for arthritogenic alphaviruses (2021) (0)
- CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS ENTRY INTO HOST CELLS OCCURS THROUGH THE MULTIVESICULAR BODY AND REQUIRES ESCRT REGULATORS (2015) (0)
- Cell Host & Microbe Resource An Immunocompetent Mouse Model of Zika Virus Infection (2018) (0)
- Forthcoming papers (2007) (0)
- A single amino acid substitution in PB1 of pandemic H1N1 with A/Ann Arbor/6/60 master donor virus mutations as a novel live-attenuated influenza virus vaccine (2022) (0)
- Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains (2015) (0)
- InfectionsChoriomeningitis Virus and Influenza Virus Cells Are Generated after Lymphocytic T + Qualitatively Different Memory CD8 (2010) (0)
- Molecular basis for the exploitation of nuclear mRNA export by influenza A virus (2020) (0)
- MHC class II proteins mediate cross-species entry of bat influenza viruses (2019) (0)
- IGHV4-34 B-Cell Receptor Immunoglobulins from CLL Stereotyped Subset 4 React with Influenza A Virus: Requirement for IGHV-D-J/Iglv-J Rearrangement and Isotype Switching to IgG (2014) (0)
- Faculty Opinions recommendation of Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults. (2013) (0)
- Systems for expression of recombinant Newcastle disease virus RNA and vaccines (1999) (0)
This paper list is powered by the following services:
Other Resources About Adolfo García-Sastre
What Schools Are Affiliated With Adolfo García-Sastre?
Adolfo García-Sastre is affiliated with the following schools:
